SARS-CoV-2 Infection: Modulator of Pulmonary Embolism Paradigm
Open Access
- 4 March 2021
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (5), 1064
- https://doi.org/10.3390/jcm10051064
Abstract
Pulmonary embolism (PE) is a life-threatening complication arising from venous thromboembolism with a difficult diagnosis and treatment and is often associated with increased mortality and morbidity. PE had a significantly low incidence prior to the COVID-19 epidemic. This condition saw a sharp surge during the COVID-19 pandemic, indicating an evident viral influence on PE’s pathophysiology in COVID-19 patients. The hypercoagulable state induced by the viral load seems to be the major contributor, and the classical causative factors seem to play a lesser role. PE in COVID-19 infection has become a mammoth challenge since the diagnosis is quite challenging due to overlapping symptoms, lack of prior-known predisposing risk factors, limited resources, and viral transmittance risk. Numerous factors arising out of the viral load or treatment lead to an increased risk for PE in COVID-19 patients, besides the fact that certain unknown risk factors may also contribute to the incidence of PE in COVID-19 patients. The management of PE in COVID-19 infection mainly comprises thromboprophylaxis and anticoagulant therapy with mechanical ventilation, depending on the risk stratification of the patient, with a post-COVID-19 management that prevents recurrent PE and complications. This review aims to discuss various aspects of COVID-19-infection-associated PE and major differential aspects from non-COVID-19 PE.This publication has 125 references indexed in Scilit:
- The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activitiesJournal of Thrombosis and Haemostasis, 2016
- Reduced thrombosis in Klkb1−/− mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factorBlood, 2015
- Pulmonary Embolectomy in the Treatment of Submassive and Massive Pulmonary EmbolismCardiology, 2014
- Diagnosis and treatment of pulmonary embolism: a multidisciplinary approachMultidisciplinary Respiratory Medicine, 2013
- Acute Right Ventricular Failure in the Setting of Acute Pulmonary Embolism or Chronic Pulmonary Hypertension: A Detailed Review of the Pathophysiology, Diagnosis, and ManagementCurrent Cardiology Reviews, 2008
- Pulmonary embolism: pathophysiology, diagnosis, treatment.2007
- The relationship between ABO histo‐blood group, factor VIII and von Willebrand factorTransfusion Medicine, 2001
- VENOUS THROMBOEMBOLIC DISEASE: Acute pulmonary embolism 1: pathophysiology, clinical presentation, and diagnosisHeart, 2001
- High Plasma Levels of Factor VIII and the Risk of Recurrent Venous ThromboembolismThe New England Journal of Medicine, 2000
- The problems of the clinical and laboratory diagnosis of pulmonary embolismSeminars in Nuclear Medicine, 1991